Skip to content

KMTS KMTS Gain/Loss on Asset Sales

Gain/Loss on Asset Sales at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
-$67K+23.0%
Haemonetics logo
HaemoneticsHAE
$178K-84.2%
ICU Medical logo
ICU MedicalICUI
-$136K+92.0%

Other financials

Income statement

See full
Revenue$24.6M+62.7%
Gross profit$12.9M+97.1%
Operating income-$34.8M-68.8%
Net income-$34.2M-58.8%
EPS (diluted)-$0.61+51.2%

Balance sheet

See full
Cash & equivalents$291.3M+436%
Total debt$43.8M
Total assets$379.3M

Cash flow

See full
Operating cash flow-$18.4M-2.1%
CapEx$9.8M+141%
Free cash flow-$28.2M-27.7%

Valuation

See full
Market cap$1.32B+70.8%
Enterprise value$1.07B
P/S15.7×

Profitability

See full
Gross margin48.8%+15.1pp
Operating margin-171.5%+12.9pp
Net margin-173%+0.8pp
FCF margin-142.9%-25.3pp

Returns & leverage

See full
Current ratio7.3×

Where this comes from

Reported directly by KMTS in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfPropertyPlantEquipment.

The official record: KMTS’s 10-Q, filed March 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about KMTS's gain/loss on asset sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KMTS's gain/loss on asset sales?
KMTS (KMTS) reported gain/loss on asset sales of -$167K in Q4 2025.
How has KMTS's gain/loss on asset sales changed year-over-year?
KMTS's gain/loss on asset sales increased by 44.7% year-over-year, from -$302K to -$167K.
What does gain/loss on asset sales mean?
Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.